CLINICAL TRIALS PROFILE FOR CORT118335

Clinical Trials for CORT118335

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT03315338 ↗	First-in-human Study in Healthy Subjects	Completed	Corcept Therapeutics	Phase 1	This initial Phase I study will evaluate the safety, tolerability, and pharmacokinetics (PK) of single and multiple ascending doses of CORT118335, the effect of concomitant administration with food on exposure to CORT118335, and its pharmacological effect in healthy subjects.
NCT03818256 ↗	This Phase 2, Double Blind, Placebo-controlled, Randomized Study is to Assess the Safety and Efficacy of Miricorilant in Obese Adult With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications.	Recruiting	Corcept Therapeutics	Phase 2	This phase 2, double blind, placebo-controlled, randomized study is to assess the safety and efficacy of miricorilant in obese adult with schizophrenia treated with antipsychotic medications.
NCT03823703 ↗	Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)	Terminated	Corcept Therapeutics	Phase 2	This phase 2, double blind, placebo-controlled, randomized study is to assess the safety and efficacy of miricorilant (CORT118335) in patients with presumed Nonalcoholic Steatohepatitis (NASH).

Clinical Trial Conditions for CORT118335

Condition Name

Condition Name
Intervention	Trials
Healthy	3
Nonalcoholic Steatohepatitis (NASH)	3
Antipsychotic-induced Weight Gain (AIWG)	2

Condition MeSH

Condition MeSH
Intervention	Trials
Non-alcoholic Fatty Liver Disease	5
Fatty Liver	5
Weight Gain	4

Clinical Trial Locations for CORT118335

Trials by Country

Trials by Country
Location	Trials
United States	61
United Kingdom	4
Puerto Rico	1

Trials by US State

Trials by US State
Location	Trials
Florida	7
California	5
Texas	5
Washington	4
New York	4

Clinical Trial Progress for CORT118335

Clinical Trial Phase

Clinical Trial Phase
Clinical Trial Phase	Trials
Phase 2	5
Phase 1	7

Clinical Trial Status

Clinical Trial Status
Clinical Trial Phase	Trials
Recruiting	6
Completed	4
Terminated	1

Clinical Trial Sponsors for CORT118335

Sponsor Name

Sponsor Name
Sponsor	Trials
Corcept Therapeutics	11
National Institute on Alcohol Abuse and Alcoholism (NIAAA)	1
The Scripps Research Institute	1

Sponsor Type

Sponsor Type
Sponsor	Trials
Industry	11
NIH	1
Other	1